Targeting altered Nme heterooligomerization in disease?

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Abu-Taha, Issam H. (VerfasserIn) , Vettel, Christiane (VerfasserIn) , Wieland, Thomas (VerfasserIn)
Dokumenttyp: Article (Journal)
Sprache:Englisch
Veröffentlicht: November 27, 2017
In: OncoTarget
Year: 2017, Jahrgang: 9, Heft: 2, Pages: 1492-1493
ISSN:1949-2553
DOI:10.18632/oncotarget.22716
Online-Zugang:Verlag, Volltext: http://dx.doi.org/10.18632/oncotarget.22716
Verlag, Volltext: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5788576/
Volltext
Verfasserangaben:Issam H. Abu-Taha, Christiane Vettel and Thomas Wieland

MARC

LEADER 00000caa a2200000 c 4500
001 1583675841
003 DE-627
005 20230427193406.0
007 cr uuu---uuuuu
008 181113s2017 xx |||||o 00| ||eng c
024 7 |a 10.18632/oncotarget.22716  |2 doi 
035 |a (DE-627)1583675841 
035 |a (DE-576)513675841 
035 |a (DE-599)BSZ513675841 
035 |a (OCoLC)1341022726 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 33  |2 sdnb 
100 1 |a Abu-Taha, Issam H.  |d 1980-  |e VerfasserIn  |0 (DE-588)1026037328  |0 (DE-627)725955953  |0 (DE-576)371031222  |4 aut 
245 1 0 |a Targeting altered Nme heterooligomerization in disease?  |c Issam H. Abu-Taha, Christiane Vettel and Thomas Wieland 
264 1 |c November 27, 2017 
300 |a 2 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Gesehen am 13.11.2018 
700 1 |a Vettel, Christiane  |d 1975-  |e VerfasserIn  |0 (DE-588)139395288  |0 (DE-627)610534734  |0 (DE-576)311522580  |4 aut 
700 1 |a Wieland, Thomas  |d 1960-2025  |e VerfasserIn  |0 (DE-588)1033445908  |0 (DE-627)741233215  |0 (DE-576)381043339  |4 aut 
773 0 8 |i Enthalten in  |t OncoTarget  |d [Erscheinungsort nicht ermittelbar] : Impact Journals LLC, 2010  |g 9(2017), 2, Seite 1492-1493  |h Online-Ressource  |w (DE-627)63035975X  |w (DE-600)2560162-3  |w (DE-576)325343764  |x 1949-2553  |7 nnas  |a Targeting altered Nme heterooligomerization in disease? 
773 1 8 |g volume:9  |g year:2017  |g number:2  |g pages:1492-1493  |g extent:2  |a Targeting altered Nme heterooligomerization in disease? 
856 4 0 |u http://dx.doi.org/10.18632/oncotarget.22716  |x Verlag  |x Resolving-System  |3 Volltext 
856 4 0 |u https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5788576/  |x Verlag  |3 Volltext 
951 |a AR 
992 |a 20181113 
993 |a Article 
994 |a 2017 
998 |g 1033445908  |a Wieland, Thomas  |m 1033445908:Wieland, Thomas  |d 60000  |d 65400  |e 60000PW1033445908  |e 65400PW1033445908  |k 0/60000/  |k 1/60000/65400/  |p 3  |y j 
998 |g 139395288  |a Vettel, Christiane  |m 139395288:Vettel, Christiane  |d 60000  |d 65400  |e 60000PV139395288  |e 65400PV139395288  |k 0/60000/  |k 1/60000/65400/  |p 2 
998 |g 1026037328  |a Abu-Taha, Issam H.  |m 1026037328:Abu-Taha, Issam H.  |d 60000  |e 60000PA1026037328  |k 0/60000/  |p 1  |x j 
999 |a KXP-PPN1583675841  |e 3032137616 
BIB |a Y 
SER |a journal 
JSO |a {"recId":"1583675841","id":{"eki":["1583675841"],"doi":["10.18632/oncotarget.22716"]},"person":[{"display":"Abu-Taha, Issam H.","role":"aut","roleDisplay":"VerfasserIn","family":"Abu-Taha","given":"Issam H."},{"roleDisplay":"VerfasserIn","display":"Vettel, Christiane","role":"aut","given":"Christiane","family":"Vettel"},{"role":"aut","display":"Wieland, Thomas","roleDisplay":"VerfasserIn","given":"Thomas","family":"Wieland"}],"name":{"displayForm":["Issam H. Abu-Taha, Christiane Vettel and Thomas Wieland"]},"note":["Gesehen am 13.11.2018"],"physDesc":[{"extent":"2 S."}],"language":["eng"],"origin":[{"dateIssuedDisp":"November 27, 2017","dateIssuedKey":"2017"}],"relHost":[{"pubHistory":["1.2010,Mai -"],"note":["Gesehen am 16.08.2018"],"physDesc":[{"extent":"Online-Ressource"}],"recId":"63035975X","id":{"zdb":["2560162-3"],"issn":["1949-2553"],"eki":["63035975X"]},"type":{"bibl":"periodical","media":"Online-Ressource"},"origin":[{"dateIssuedDisp":"2010-","publisherPlace":"[Erscheinungsort nicht ermittelbar]","dateIssuedKey":"2010","publisher":"Impact Journals LLC"}],"title":[{"title":"OncoTarget","title_sort":"OncoTarget","subtitle":"open access impact journal"}],"language":["eng"],"disp":"Targeting altered Nme heterooligomerization in disease?OncoTarget","part":{"issue":"2","year":"2017","volume":"9","extent":"2","pages":"1492-1493","text":"9(2017), 2, Seite 1492-1493"}}],"title":[{"title_sort":"Targeting altered Nme heterooligomerization in disease?","title":"Targeting altered Nme heterooligomerization in disease?"}],"type":{"media":"Online-Ressource","bibl":"article-journal"}} 
SRT |a ABUTAHAISSTARGETINGA2720